Helicobacter pylori infection: Pathogenesis

Current Opinion in Gastroenterology

Volumn 18, Issue 1, 2002, Pages 15-25

  Fox, James G ^a   Wang, Timothy C ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CHEMOKINE; CYTOKINE; GASTRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PROTEIN P21;

ACID SECRETION; APOPTOSIS; CANCER GROWTH; CANCER RISK; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HEREDITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; PATHOGENESIS; PEPTIC ULCER; RECEPTOR UPREGULATION; REVIEW; STOMACH CARCINOMA; STOMACH DISEASE; STOMACH MUCOSA; T LYMPHOCYTE; TH1 CELL; VACCINATION;

EID: 0036137991     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200201000-00004     Document Type: Review

References (63)

1. Concurrent enteric helminth infection modulates inflammation, gastric immune responses, and reduces Helicobacter-induced gastric atrophy
2. The importance of interleukin 1beta in Helicobacter pylori associated disease
3. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice
4. Dominant nonresponsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon
5. Lack of gastritis and of an adaptive immune response in interferon regulatory factor-1-deficient mice infected with Helicobacter pylori
6. Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice
7. Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice
8. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling
9. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer
10. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia
11. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils
12. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils
13. Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice
14. Radioimmunoassay for sequence 38-54 of human progastrin: Increased diagnostic specificity of gastrin-cell diseases
15. Helicobacter pylori infection and exaggerated gastrin release: Effects of inflammation and progastrin processing
16. Expression of progastrin-derived peptides and somatostatin in fundus and antrum of nonulcer dyspepsia subjects with and without Helicobacter pylori infection
17. IV: Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation
18. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells
19. Implication of NF-kappaB in Helicobacter pylori-associated gastritis
20. Induction of monocyte chemoattractant protein 1 by Helicobacter pylori involves NF-kappaB
21. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells
22. p21-activated kinase 1 activates the nuclear factor kappa B (NF-kappa B)-inducing kinase-Ikappa B kinases NF-kappa B pathway and proinflammatory cytokines in Helicobacter pylori infection
23. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island
24. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag Helicobacter pylori
25. Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells
26. Induction of gastric epithelial apoptosis by Helicobacter pylori
27. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: Implications in gastric carcinogenesis
28. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection
29. In vivo disruption of the fas pathway abrogates gastric growth alterations secondary to Helicobacter infection
30. Increased gastric epithelial cell apoptosis associated with colonization with cagA+ Helicobacter pylori strains
31. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis
32. Acid-dependent adherence of Helicobacter pylori urease to diverse polysaccharides
33. Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1)
34. Fumarate reductase is essential for Helicobacter pylori colonization of the mouse stomach
35. Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization
36. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection
37. Interaction of Helicobacter pylori with professional phagocytes: Role of the cag pathogenicity island and translocation, phosphorylation and processing of CagA
38. Effect of Helicobacter pylori on polymorphonuclear leukocyte migration across polarized T84 epithelial cell mono-layers: Role of vacuolating toxin VacA and cag pathogenicity island
39. Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells
40. Helicobacter pylori urease suppresses bactericidal activity of peroxynitrite via carbon dioxide production
41. Helicobacter pylori pore-forming cytolysin orthologue TlyA possesses in vitro hemolytic activity and has a role in colonization of the gastric mucosa
42. Induction of host signal transduction pathways by Helicobacter pylori
43. Helicobacter pylori lipopolysaccharides preferentially induce CXC chemokine production in human monocytes
44. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
45. The complete genome sequence of the gastric pathogen Helicobacter pylori
46. Comparative genomics of Helicobacter pylori: Analysis of the outer membrane protein families
47. Quantitative detection of Helicobacter pylori gene expression in vivo and relationship to gastric pathology
48. Acid-induced gene expression in Helicobacter pylori: Study in genomic scale by microarray
49. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains
50. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses
51. Helicobacter pylori infection induced alteration of gene expression in human gastric cells
52. The protein-protein interaction map of Helicobacter pylori
53. The design of vaccines against Helicobacter pylori and their development
54. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against Helicobacter infection in mice
55. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection
56. Immunity against Helicobacter pylori: Significance of interleukin-4 receptor alpha chain status and gender of infected mice
57. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection
58. KRAS mutations predict progression of preneoplastic gastric lesions
59. KPAS mutations are not predictive for progression of preneoplastic gastric lesions
60. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study
61. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy
62. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated
63. Modeling cost effectiveness of H. pylori screening to prevent gastric cancer: A mandate for clinical trials